Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-15T05:57:37.555Z Has data issue: false hasContentIssue false
  • English
  • Français

Panic Attacks

A Neurochemical Overview of Models and Mechanisms

Published online by Cambridge University Press:  02 January 2018

David Nutt and
Christopher Lawson
David Nutt*
Affiliation:
Reckitt and Colman Psychopharmacology Unit, School of Medical Sciences, University Walk, Bristol BS8 1TD
Christopher Lawson
Affiliation:
School of Medical Sciences, Bristol; The Royal London Hospital
*
∗ Correspondence
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

The delineation of panic disorder as a distinct diagnostic entity has provided renewed impetus for research into panic. This review describes and examines the range of neurobiological theories of panic attacks. It illustrates the diversity of mechanisms that have been invoked to explain the production of panic attacks, and which have influenced much of the current thinking about the neurochemistry of anxiety.

Information

Type
Review Articles
Information
The British Journal of Psychiatry , Volume 160 , Issue 2 , February 1992, pp. 165 - 178
Copyright
Copyright © Royal College of Psychiatrists, 1992 

References

Abelson, J. L. & Nesse, R. M. (1990) Cholecystokinin-4 and panic. Archives of General Psychiatry, 47, 395.Google Scholar
Ackerman, S. H. & Sachar, E. J. (1974) The lactate theory of anxiety: a review and re-evaluation. Psychosomatic Medicine, 36, 69–81.Google Scholar
American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn) (DSM–III). Washington, DC: APA.Google Scholar
Arbab, A. G., Bonn, J. A. & Hicks, D. C. (1971) Effect of propranolol on lactate-induced phenomena in normal subjects. British Journal of Pharmacology, 41, 430.Google Scholar
Aston-Jones, G., Ennis, M., Pieribone, V. A., et al (1986) The brain nucleus locus coeruleus: restricted afferent control of a broad efferent network. Science, 234, 734–737.CrossRefGoogle ScholarPubMed
Ballenger, J. C., Burrows, G. D., Dupont, R. L., et al (1988) Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I: Efficacy in short-term treatment. Archives of General Psychiatry, 45, 413–422.Google Scholar
Barbaccia, M. C., Costa, E., Ferrero, P., et al (1986) Diazepam binding inhibitor. Archives of General Psychiatry, 43, 1143–1147.Google Scholar
Bass, C. & Gardner, W. N. (1985) Respiratory and psychiatric abnormalities in patients with chronic symptomatic hyperventilation. British Medical Journal, 290, 1387–1390.Google Scholar
Bass, C., Kartsounis, L. & Lelliott, P. (1987) Hyperventilation and its relationship to anxiety and panic. Integr. Psychiatry, 5, 274–291.Google Scholar
Beck, A. T. (1988) Cognitive approaches to panic disorder: theory and therapy. In Panic: Psychological Perspectives (eds Rachman, S. & Maser, J. D.), p. 91. New Jersey: Lawrence Erlbaum.Google Scholar
Beck, A. T., Laude, R. & Bohnert, M. (1974) Ideational components of anxiety neurosis. Archives of General Psychiatry, 31, 319–325.Google Scholar
Beinfeld, M. C. & Palkovits, M. (1981) Distribution of cholecystokinin in the hypothalamus and the limbic system of the rat. Neuropeptides, 2, 123–129.Google Scholar
Berkowitz, B. A., Travers, J. H. & Spector, S. (1970) Release of norepinephrine in the CNS by theophylline and caffeine. European Journal of Pharmacology, 10, 64–71.Google Scholar
Bonn, J. A., Harrison, J. & Linford-Rees, W. (1971) Lactate-induced anxiety: therapeutic application. British Journal of Psychiatry, 119, 468–470.Google Scholar
Boulenger, J. P., Bierer, L. M. & Uhde, T. W. (1986) Anxiogenic effects of caffeine in normal controls and patients with panic disorder. Biological Psychiatry, 22, 454–456.Google Scholar
Bradwejn, J. & De Montigny, C. (1984) Benzodiazepines antagonise cholecystokinin induced activation of rat hippocampal neurones. Nature, 312, 363–364.Google Scholar
Braestrup, C. & Squires, R. F. (1978) Brain specific benzodiazepine receptors. British Journal of Psychiatry, 133, 249–260.Google Scholar
Braestrup, C., Nielsen, M., Honore, T., et al (1983) Benzodiazepine receptor ligands with positive and negative efficacy. Neuropharmacology, 22, 1451–1457.Google Scholar
Brash ear, R. E. (1983) Hyperventilation syndrome. Lung, 161, 257–273.Google Scholar
Bruce, M. S. & Lader, M. (1989) Caffeine abstention in the management of anxiety disorders. Psychological Medicine, 19, 211–214.Google Scholar
Cannon, W. B. (1929) Bodily Changes in Pain, Hunger, Fear and Death. New York: Applet on.Google Scholar
Cantril, H. & Hunt, W. A. (1932) Emotional effects produced by the injection of adrenaline. American Journal of Psychology, 44, 300–307.Google Scholar
Carr, D. B. & Sheehan, D. V. (1984) Panic anxiety: a new biological model. Journal of Clinical Psychiatry, 45, 323–330.Google ScholarPubMed
Charney, D. S. & Redmond, D. E. (1983) Neurobiological mechanisms in human anxiety. Neuropharmacology, 22, 1531–1536.CrossRefGoogle ScholarPubMed
Charney, D. S., Heninger, G. R. & Breier, A. (1984a) Noradrenergic function and panic anxiety effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Archives of General Psychiatry, 41, 751–763.Google Scholar
Charney, D. S., Galloway, M. P. & Heninger, G. R. (1984b) The effects of caffeine on plasma MHPG, subjective anxiety, autonomic symptoms and blood pressure in healthy humans. Life Sciences, 35, 135–144.Google Scholar
Charney, D. S., Heninger, G. R. & Jatlow, P. I. (1985) Increased anxiogenic effects of caffeine in panic disorders. Archives of General Psychiatry, 42, 233–243.Google Scholar
Charney, D. S. & Heninger, G. R. (1986) Abnormal regulation of noradrenergic function in panic disorders. American Journal of Psychiatry, 43, 1042–1054.Google Scholar
Charney, D. S., Woods, S. W., Goodman, W. K., et al (1987) Serotonin function in anxiety: II. Effects of the serotonin agonist mCPP in panic disorder patients and healthy subjects. Psychopharmacology, 92, 14–24.Google Scholar
Chignon, J. M. & Lepine, E. P. (1989) Panic and hypertension associated with a single dose of buspirone. Lancet, ii, 46–47.CrossRefGoogle Scholar
Chouinard, G., Annable, L., Fontaine, R., et al (1982) Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind, placebo-controlled study. Psychopharmacology, 77, 229–233.Google Scholar
Clark, D. M. (1986) A cognitive approach to panic. Behavioural Research and Therapy, 24, 461–470.Google Scholar
Clark, D. M. (1988) A cognitive model of panic attacks. Panic: Psychological Perspectives (eds Rachman, S. & Maser, J. D.), p. 71. New Jersey: Lawrence Erlbaum.Google Scholar
Clark, D. M. & Hemsley, D. R. (1982) The effects of hyperventilation: individual variability and its relation to personality. Journal of Behaviour Therapy and Experimental Psychiatry, 13, 41–47.Google Scholar
Clark, D. M., Salkovskis, P. M. & Chalkley, A. J. (1985) Respiratory control as a treatment for panic attacks. Journal of Behaviour Therapy and Experimental Psychiatry, 16, 23–30.CrossRefGoogle ScholarPubMed
Clifford, J. N., Hoare, R. C., Jennings, M., et al (1989) Safety, tolerance and disposition of efaroxan in healthy non-patient volunteers. British Journal of Clinical Pharmacology, 28, pp. 217 218.Google Scholar
Clow, A., Glover, V., Armando, I., et al (1983) New endogenous benzodiazepine receptor ligand in human urine: identity with endogenous monoamine oxidase inhibitor? Life Sciences, 33, 735–741.CrossRefGoogle ScholarPubMed
Clow, A., Glover, V., Sandler, M., et al (1988a) Increased urinary tribulin output in generalised anxiety disorder. Psychopharmacology, 95, 378–380.Google Scholar
Clow, A., Glover, V., Weg, W. M., et al (1988b) Urinary catecholamine metabolism and tribulin output during lactate infusion. British Journal of Psychiatry, 152, 122–126.Google Scholar
Cohen, M. E., Consolzaio, F. C. & Johnson, R. E. (1947) Blood lactate response during moderate exercise in neurocirculatory asthenia, anxiety neurosis, or effort syndrome. Journal of Clinical Investigation, 26, 339–342.Google Scholar
Coryell, W., Noyes, R. & Clancy, J. (1982) Excess mortality in panic disorder: a comparison with primary unipolar depression. Archives of General Psychiatry, 39, 701–703.Google Scholar
Cowley, D. S. & Arana, G. W. (1990) The diagnostic utility of lactate sensitivity in panic disorder. Archives of General Psychiatry, 47, 277–284.Google Scholar
Crowe, R. R., Noyes, R., Wilson, A. F., et al (1987) A linkage study of panic disorder. Archives of General Psychiatry, 44, 933–937.Google Scholar
Dacosta, J. M. (1871) On irritable heart; a clinical study of a form of functional cardiac disorder and its consequences. American Journal of Medical Science, 61, 17–52.Google Scholar
De Montiony, C. (1989) Cholecystokinin tetrapeptide induces panic like attacks in healthy volunteers. Archives of General Psychiatry, 46, 511–517.CrossRefGoogle Scholar
Dockray, G. J. (1976) Immunochemical evidence of chofecystokinin$like peptide in brain. Nature, 264, 568–570.Google Scholar
Dorow, R., Horowski, R., Paschelke, G., et al (1983) Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors. Lancet, ii, 98–99.Google Scholar
Ehlers, A., Margraf, J., Roth, W. T., et al (1986) Lactate infusions and panic attacks: do patients and controls respond differently? Psychiatry Research, 17, 295–308.Google Scholar
Elam, M., Yao, T., Thoren, P., et al (1981) Hypercapnia and hypoxia: chemoreceptor-mediated control of locus coemleus neurons and splanchnic sympathetic nerves. Brain Research, 222, 373–381.Google Scholar
Fisher, L. A. (1989) Corticotrophin-releasing factor: endocrine and autonomic integration of responses to stress. Trends in Pharmacological Sciences, 10, 189–193.Google Scholar
Frankenhaeuser, M., Jarpe, G. & Matell, G. (1961) Effects of intravenous infusions of adrenaline and noradrenaline on certain psychological and physiological functions. Acta Physiologica Scandinavica, 51, 175–186.Google Scholar
Frazer, G. A. & Lapierre, Y. D. (1987) The effect of buspirone on panic disorder: a case report. Journal of Clinical Psychopharmacology, 7, 118–119.Google Scholar
Freud, S. (1924) The justification for detaching from neurasthenia a particular syndrome: the anxiety-neurosis. In Collected Works. London: Hogarth Press.Google Scholar
Gelder, M. G. (1989a) Panic disorder: fact or fiction? Psychological Medicine, 19, 277–283.Google Scholar
Gelder, M. G. (1989b) The classification of anxiety disorders. British Journal of Psychiatry, 154, (suppl. 4), 28–32.Google Scholar
Gentil, V., Tavares, S., Gorenstein, C., et al (1990) Acute reversal of flunitrazepam effects by Ro 15–1788 and Ro 15–3505: inverse agonism, tolerance and rebound. Psychopharmacology (Berlin), 100, 54–59.Google Scholar
George, D. T., Nutt, D. J., Walker, W. V., et al (1989) Lactate and hyperventilation substantially attenuate vagal tone in normal volunteers. Archives of General Psychiatry, 46, 153–156.Google Scholar
George, D. T., Glue, P., Bacher, J. D., et al (1990a) Lactate-induced electrolyte changes in the cerebrospinal fluid of rabbits. Biological Psychiatry, 27, 104–108.Google Scholar
George, D. T., Adinoff, B., Razvitz, B., et al (1990b) A cerebrospinal fluid study of the pathophysiology of panic disorder associated with alcoholism. Acta Psychiatrica Scandinavica, 82, 1–7.Google Scholar
Goa, K. L. & Ward, A. (1986) Buspirone. Drugs, 32, 114–129.Google Scholar
Goldberg, M. R., Hollister, A. S. & Robertson, D. (1983) Influence of yohimbine on blood pressure, autonomic reflexes and plasma catecholamines in humans. Hypertension, 5, 772–778.Google Scholar
Goldstein, A., Serber, M. & Piaget, J. (1970) Induced anger as a reciprocal inhibitor of fear. Journal of Behaviour Therapy and Experimental Psychology, 1, 67.Google Scholar
Gorman, J. M., Askanazi, J., Liebowitz, J. R., et al (1984a) Response to hyperventilation in a group of patients with panic disorder. American Journal of Psychiatry, 141, 857–861.Google Scholar
Gorman, J. M., Martinez, J., Liebowitz, M. R., et al (1984b) Hypoglycemia and panic attacks. American Journal of Psychiatry, 141, 101–102.Google Scholar
Gorman, J. M., Fyer, M. R., Goetz, R., et al (1988) Ventilatory physiology of patients with panic disorder. Archives of General Psychiatry, 45, 31–39.Google Scholar
Gorman, J. M., Liebowitz, M. R., Fyer, A. J., et al (1989a) A neuroanatomical hypothesis for panic disorder. American Journal of Psychiatry, 146, 148–161.Google Scholar
Gorman, J. M., Battista, D., Goetz, R. R., et al (1989b) A comparison of sodium bicarbonate and sodium lactate infusion in the induction of panic attacks. Archives of General Psychiatry, 46, 145–150.Google Scholar
Gorman, J. M., Goetz, R. R., Dillon, D., et al (1990) Sodium d-lactate infusion in panic disorder patients. Neuropsychopharmacology, 3, 181–189.Google Scholar
Gray, P. W., Glaister, D., Seeburg, P. H., et al (1986) Cloning and expression of cDNA for human diazepam binding inhibitor, a natural ligand of the GABA receptor. Proceedings of the National Academy of Science (USA), 83, 7547–7551.Google Scholar
Greden, J. F., Fontaine, P., Lubetsky, M., et al (1979) Anxiety and depression associated with caffeinism among psychiatric inpatients. American Journal of Psychiatry, 135, 963–966.Google Scholar
Griez, E., Lousberg, H., Van den Hour, M. A., et al (1987) Carbon dioxide vulnerability in panic disorder. Psychiatry Research, 20, 87–95.CrossRefGoogle ScholarPubMed
Grosz, H. J. & Farmer, B. B. (1969) Blood lactate in the development of anxiety symptoms. Archives of General Psychiatry, 21, 611–619.Google Scholar
Grosz, H. J. & Farmer, B. B. (1972) Pitt's and McClure's lactate–anxiety study revisited. British Journal of Psychiatry, 120, 415–418.Google Scholar
Haslam, M. T. (1974) The relationship between the effect of lactate infusion on anxiety states and the amelioration by carbon dioxide inhalation. British Journal of Psychiatry, 125, 88–90.Google Scholar
Hayward, C., Clark, D. B. & Barr Taylor, C. (1990) Panic disorder, anxiety, and cardiovascular risk. Clinical Aspects of Panic Disorder (ed. Ballenger, J. C.), p. 99. New York: Wiley–Liss.Google Scholar
Hibbert, G. A. (1984a) Hyperventilation as a cause of panic attacks. British Medical Journal, 288, 263–264.Google Scholar
Hibbert, G. A. (1984b) Ideational components of anxiety: their origin and content. British Journal of Psychiatry, 144, 618–624.Google Scholar
Hibbert, G. A. & Pilsbury, D. (1988) Hyperventilation in panic attacks: ambulant monitoring of transcutaneous carbon dioxide. British Journal of Psychiatry, 153, 76–80.Google Scholar
Hibbert, G. A. & Pilsbury, D. (1989) Hyperventilation: is it a cause of panic attacks? British Journal of Psychiatry, 155, 805–809.Google Scholar
Hoehn-Saric, R., Merchant, A. F., Keyser, M. C., et al (1981) Effects of clonidine on anxiety disorders. Archives of General Psychiatry, 38, 1278–1282.Google Scholar
Jones, M. & Mellersh, V. (1946) A comparison of the exercise response in anxiety states and normal controls. Psychosomatic Medicine, 8, 180–187.Google Scholar
Kahn, R. S. & Westenberg, H. M. G. (1985) 1–5-hydroxytryptophan in the treatment of anxiety disorders. Journal of Affective Disorders, 8, 197–200.Google Scholar
Kahn, R. S., Asnis, G. M., Wetzler, S., et al (1988) Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder. Psychopharmacology, 96, 360–364.Google Scholar
Kalinowski, L. B. & Hoch, P. H. (1961) Somatic Treatments in Psychiatry. New York: Grune and Stratton.Google Scholar
Klein, D. F. (1964) Delineation of two drug responsive anxiety syndromes. Psychopharmacologica (Berlin), 5, 397–408.Google Scholar
Klein, D. F. (1981) Anxiety reconceptualized. In Anxiety: New Research and Changing Concepts (eds Klein, D. F. & Rabkin, J.), pp. 235–263. New York: Raven Press.Google Scholar
Ko, G. N., Elsworth, J. D., Roth, R. H., et al (1983) Panic-induced elevation of plasma MHPG levels in phobic-anxious patients: effects of clonidine and imipramine. Archives of General Psychiatry, 40, 425–430.Google Scholar
Koenigsberg, C. (1987) The sleep lactate infusion: arousal and the panic mechanism. Proceedings of the Royal College of Psychiatrists, (abstract).Google Scholar
Koob, G. & Bloom, F. E. (1985) Corticotropin-releasing factor and behaviour. Fed. Proc., 44, 259–265.Google Scholar
Lader, M. & Bruce, M. (1986) States of anxiety and their induction by drugs. British Journal of Clinical Pharmacology, 22, 251–261.Google Scholar
Lee, M. A., Flegel, P., Greden, J. F., et al (1988) Anxiogenic effects of caffeine on panic and depressed patients. American Journal of Psychiatry, 145, 632–635.Google Scholar
Liebowitz, M. R., Fyer, A. J., Gorman, J. M., et al (1984a) Lactate provocation of panic attacks. Archives of General Psychiatry, 41, 764–770.Google Scholar
Liebowitz, M. R., Gorman, J. M., Fyer, A. J., et al (1984b) Lactate provocation of pain attacks: II. Biochemical and physiological findings. Archives of General Psychiatry, 42, 709–719.CrossRefGoogle Scholar
Liebowitz, M. R., Fyer, A. J., Gorman, J. M., et al (1985) Specificity of lactate infusions in social phobia versus panic disorders. American Journal of Psychiatry, 142, 947–950.Google Scholar
Liebowitz, M. R., Gorman, J. M., Fyer, A. J., et al (1986) Possible mechanisms for lactate's induction of panic. American Journal of Psychiatry, 143, 495–502.Google Scholar
Lingjaerde, O. (1985) Lactate-induced panic attacks: possible involvement of serotonin reuptake stimulation. Acta Psychiatrica Scandinavica, 72, 206–208.Google Scholar
Little, H. J., Nutt, D. J. & Taylor, S. C. (1987) Bidirectional effects of chronic treatment with agonists and inverse agonists at the benzodiazepine receptor. Brain Research Bulletin, 19, 371–378.Google Scholar
Louie, A. K., Canno, R. A. & Ketter, T. A. (1989) Treatment of cocaine induced panic disorder. American Journal of Psychiatry, 146, 40–44.Google Scholar
Lum, L. C. (1976) The syndrome of habitual chronic hyperventilation. In Modern Trends in Psychosomatic Medicine, vol. 3 (ed. Hill, O. W.), pp. 196–230. London: Butterworths.Google Scholar
Macmillan, V. & Siesjo, B. K. (1973) The influence of hypocapnia upon intracellular pH and upon some carbohydrate substrates, amino acids and organic phosphates in the brain. Journal of Neurochemistry, 21, 1283–1299.Google Scholar
Maranon, G. (1924) Contribution a l'étude de Taction emotive de 1'adrenaline. Revue Française d'Endocrinologie, 2, 301–325.Google Scholar
Margraf, J., Ehlers, A. & Roth, W. T. (1986) Sodium lactate infusions and panic attacks: a review and critique. Psychosomatic Medicine, 48, 23–51.Google Scholar
Markowitz, J. S., Weissman, M. M., Ouellette, R., et al (1989) Quality of life in panic disorder. Archives of General Psychiatry, 46, 984–992.Google Scholar
Marks, I. M. (1987) Fears, Phobias and Rituals. New York: Oxford University Press.Google Scholar
Mathias, C. J., Frankel, H. L., Tuner, R. C., et al (1979) Physiological responses to insulin hypoglycaemia in man. Paraplegia, 17, 319–326.Google Scholar
Mavissakalian, M. & Perel, J. (1985) Imipramine in the treatment of agoraphobia: dose-response relationships. American Journal of Psychiatry, 142, 1032–1036.Google Scholar
Mellman, T. A. & Uhde, T. W. (1989) EEG sleep in panic disorder. Archives of General Psychiatry, 46, 178–184.Google Scholar
Middleton, H. C. (1990) Cardiovascular dystonia in recovered panic patients. Journal of Affective Disorders, 19, 229–236.Google Scholar
Middleton, H. C. (1991) An enhanced hypotensive response to clonidine can still be found in panic patients despite psychological treatment. Journal of Affective Disorders, in press.Google Scholar
Nesse, R. M., Cameron, O. G., Curtis, G. C., et al (1984) Adrenergic function in patients with panic anxiety. Archives of General Psychiatry, 41, 771–776.Google Scholar
Noyes, R., Anderson, D. J., Clancy, J., et al (1984) Diazepam and propranolol in panic disorder and agoraphobia. Archives of General Psychiatry, 41, 287–292.Google Scholar
Nutt, D. J. (1986) Increased central alpha-2–adrenoceptor sensitivity in panic disorder. Psychopharmacology, 90, 268–269.Google Scholar
Nutt, D. J. (1989) Altered alpha-2–adrenoceptor sensitivity in panic disorder. Archives of General Psychiatry, 46, 165–169.Google Scholar
Nutt, D. J. (1990) The pharmacology of human anxiety. Pharmacology and Therapeutics, 47, 233–266.Google Scholar
Nutt, D. J. & Cowen, P. J. (1987) Monoamine function in anxiety and depression: information from neuroendocrine challenge tests. Human Psychopharmacology, 2, 211–220.Google Scholar
Nutt, D. J. & Costello, M. (1988) Rapid induction of lorazepam dependence and its reversal with flumazenil. Life Sciences, 43, 1045–1053.Google Scholar
Nutt, D. J. & George, D. T. (1989) Serotonin and anxiety. In Handbook of Anxiety (eds Roth, M., Burrows, G. D. & Noyes, R.). Amsterdam: Elsevier.Google Scholar
Nutt, D. J. & Glue, P. (1989) Clinical pharmacology of anxiolytics and antidepressants: a psychopharmacological perspective. Pharmacology and Therapeutics, 44, 309–334.Google Scholar
Nutt, D. J., Glue, P., Lawson, C. W., et al (1990a) Flumazenil provocation of panic attacks: evidence for altered benzodiazepine receptor sensitivity in panic disorder. Archives of General Psychiatry, 47, 917–925.Google Scholar
Nutt, D. J., Glue, P. & Lawson, C. W. (1990b) The neurochemistry of anxiety. Progress in Neuropsychopharmacology and Biological Psychiatry, 14, 737–752.Google Scholar
Nutt, D. J., Glue, P., Lawson, C. W., et al (1991) Do Benzodiazepine Receptors have a Causal Role in Panic Disorder? BAP Monograph. Oxford University Press.Google Scholar
Pitts, F. M. & McClure, J. N. (1967) Lactate metabolism in anxiety neurosis. New England Journal of Medicine, 277, 1329–1336.Google Scholar
Pitts, F. M. & Allen, R. E. (1979) Biochemical induction of anxiety. In Phenomenology and Treatment of Anxiety (eds Fann, W. E., Karacen, I., Pokorny, A. P., et al). New York: Spectrum Publications.Google Scholar
Pyke, R. E. & Greenberg, H. S. (1986) Norepinephrine challenges in panic patients. Journal of Clinical Pharmacology, 6, 279–285.Google Scholar
Rainey, J. M., Pohl, R. B., Williams, M., et al (1984) A comparison of lactate and isoproterenol anxiety states. Psychopathology, 17 (suppl. 1), 74–82.Google Scholar
Rapee, R. (1985) The distinction between panic disorder and generalised anxiety disorder. Australian and New Zealand Journal of Psychiatry, 19, 227–232.Google Scholar
Rasmussen, K. & Jacobs, B. L. (1986) Single unit activity of locus coeruleus neurons in freely moving cat: II. Conditioning and pharmacologic studies. Brain Research, 371, 335–344.Google Scholar
Redmond, D. E. (1985) Neurochemical basis for anxiety and anxiety disorders: evidence from drugs which decrease human fear or anxiety. In Anxiety and the Anxiety Disorders (eds Tuma, A. H. & Maser, J. D.), pp. 530–555. Hillsdale, NJ: Lawrence Erlbaum Associates.Google Scholar
Redmond, D. E. (1986) The possible role of locus coeruleus noradrenergic activity in anxiety-panic. Clinical Neuropharmacology, 9 (suppl. 4), 40–42.Google Scholar
Redmond, D. E. & Huang, Y. (1979) Current concepts: II. New evidence for a locus coeruleus–norepinephrine connection with anxiety. Life Sciences, 25, 2149–2162.Google Scholar
Regier, D. A., Jeffrey, H. B., Burke, J. D., et al (1988) One-month prevalence of mental disorders in the United States. Archives of General Psychiatry, 45, 977–986.CrossRefGoogle ScholarPubMed
Reid, J. C. (1983) Central and peripheral autonomic control mechanisms. Autonomic Failure (ed. Bannister, R.), p. 17. Oxford: Oxford University Press.Google Scholar
Reiman, E. M., Raichle, M. E., Robins, E., et al (1989) Neuranatomical correlates of a lactate-induced anxiety attack. Archives of General Psychiatry, 46, 493–500.Google Scholar
Rifkin, A., Klein, D. F., Dillon, D. J., et al (1981) Blockade by imipramine or desipramine of panic induced by sodium lactate. American Journal of Psychiatry, 138, 676–677.Google Scholar
Ritter, J. M., Dokotor, H. S. & Benjamin, N. (1990) Paradoxical effect of bicarbonate on cytoplasmic pH. Lancet, 335, 1243–1246.Google Scholar
Roy-Byrne, P. P., Geraci, M. & Uhde, T. W. (1986) Life events and course of illness in patients with panic disorder. American Journal of Psychiatry, 143, 1033–1035.Google Scholar
Roy-Byrne, P. P., Lewis, N., Villacres, E., et al (1989) Preliminary evidence of benzodiazepine subsensitivity in panic disorder. Biological Psychiatry, 26, 744–748.Google Scholar
Roy-Byrne, P. P., Cowley, D. S., Greenblatt, D. J., et al (1990) Reduced benzodiazepine sensitivity in panic disorder. Archives of General Psychiatry, 47, 534–538.Google Scholar
Salkovskis, P. M. (1988) Phenomenology, assessment, and the cognitive model of panic. Panic: Psychological Perspectives (ed. Rachman, S. & Maser, J. D.), p. 111. New Jersey: Lawrence Erlbaum.Google Scholar
Salkovskis, P. M., Jones, D. R. O. & Clark, D. M. (1986) Respiratory control in the treatment of panic attacks: replication and extension with concurrent measurement of behaviour and pCO2 . British Journal of Psychiatry, 148, 526–532.Google Scholar
Sanderson, W. C., Rapee, R. M. & Barlow, D. H. (1989) The influence of an illusion of control on panic attacks induced via inhalation of 5.5% carbon dioxide-enriched air. Archives of General Psychiatry, 46, 157–162.Google Scholar
Schachter, S. & Singer, J. (1962) Cognitive social and physiological determinants of emotional state. Psychological Review, 69, 379–397.Google Scholar
Schofield, P. R., Darlison, M. G., Fujita, N., et al (1987) Sequence and functional expression of the GABA-A-receptor shows a ligand-gated receptor super family. Nature (Lond.), 328, 221–227.Google Scholar
Schweizer, E., Winokur, A. & Rickels, K. (1986) Insulin-induced hypoglycemia and panic attacks. American Journal of Psychiatry, 143, 654–655.Google Scholar
Slater, S. L. & Levy, A. (1966) The effects of inhaling a 35% carbon dioxide – 65% oxygen mixture upon anxiety in neurotic patients. Behavioural Research and Therapy, 4, 309–316.Google Scholar
Snyder, S. H., Katims, J. J., Annau, Z., et al (1981) Adenosine receptors and behavioural actions of methylxanthines. Proceedings of the National Academy of Science, 78, 3260–3264.Google Scholar
Stanford, S. C. (1989) Central adrenoceptors in response and adaptation to stress. In The Pharmacology of Noradrenaline in the Central Nervous System (eds Marsden, C. A. & Heal, D. J.). Oxford University Press.Google Scholar
Starkman, M. N., Zelnik, T. C., Nesse, R. M., et al (1985) Anxiety in patients with phaechromocytoma. Archives of Internal Medicine, 145, 248–252.Google Scholar
Stein, M. B. & Uhde, T. W. (1991) Endocrine, cardiovascular, and behavioral effects of intravenous Protirelin in patients with panic disorder. Archives of General Psychiatry, 48, 148–156.Google Scholar
Stone, E. A. (1983) Problems with current catecholamine hypotheses of antidepressant agents: speculations leading to a new hypothesis. Behavioural and Brain Sciences, 6, 535–577.Google Scholar
Taylor, D. P., Eison, M. S., Riblet, L. A., et al (1985) Pharmacological and clinical effects of buspirone. Pharmacology Biochemistry and Behavior, 23, 687–694.Google Scholar
Torgersen, S. (1983) Genetic factors in anxiety disorders. Archives of General Psychiatry, 40, 1085–1089.Google Scholar
Uhde, T. (1990) Caffeine and panic attacks. Neurobiology of Panic Disorder (ed. Ballenger, J. C.). New York: Wiley–Liss.Google Scholar
Uhde, T., Boulenger, J. P., Post, R. M., et al (1984a) Fear and anxiety: relationship to noradrenergic function. Psychopathology, 17 (suppl. 3), 8–23.CrossRefGoogle ScholarPubMed
Uhde, T., Boulenger, J. P., Jimerson, D. C., et al (1984b) Caffeine: relationship to human anxiety, plasma MHPG and Cortisol. Psychopharmacology Bulletin, 20, 426–430.Google Scholar
Uhde, T., Vittone, B. J. & Post, R. M. (1984c) Glucose tolerance testing in panic disorder. American Journal of Psychiatry, 141, 1461–1463.Google Scholar
Uhde, T., Stein, M. B., Vittone, B. J., et al (1989) Behavioral and physiologic effects of short-term and long-term administration of clonidine in panic disorder. Archives of General Psychiatry, 46, 170–177.Google Scholar
Van den Holt, M. A. (1988) The explanation of experimental panic. Panic: Psychological Perspectives (ed. Rachman, J. & Maser, J. D.), p. 237. New Jersey: Lawrence Erlbaum.Google Scholar
Van den Holt, M. A. & Griez, E. (1984) Panic symptoms after inhalation of carbon dioxide. British Journal of Psychiatry, 144, 503–507.Google Scholar
Villacres, E. C., Hollifield, M., Katon, W. J., et al (1987) Sympathetic nervous system activity in panic disorder. Psychiatry Research, 21, 313–321.Google Scholar
von Korff, M., Eaton, W. & Keyl, P. (1985) The epidemiology of panic attacks and panic disorder: results of three community surveys. American Journal of Epidemiology, 122, 970–981.Google Scholar
Waeber, R., Adler, R. H., Schwank, A., et al (1982) Dyspnea proneness to CO2 stimulation and personality (neuroticism, extraversion, MMPI factors). Psychotherapy and Psychosomatics, 37, 119–123.Google Scholar
Weissman, M. W. (1990) Epidemiology of panic disorder and agoraphobia. Clinical Aspects of Panic Disorder (ed. Ballenger, J. C.), p. 57. New York: Wiley–Liss.Google Scholar
Weissman, M. W., Klerman, G. L., Markowitz, J. S., et al (1989) Suicidal ideation and suicide attempts in panic disorder and attacks. New England Journal of Medicine, 321, 1209–1214.Google Scholar
Westenberg, H. G. M. & Den Boer, J. A. (1989) Serotonin function in panic disorder: effect of l-5-hydroxytryptophan in patients and controls. Psychopharmacology, 98, 283–285.Google Scholar
Wolpe, J. (1958) Psychotherapy by Reciprocal Inhibition. California: Stanford University Press.Google Scholar
Wolpe, J. (1982) The Practice of Behaviour Therapy. New York: Pergamon.Google Scholar
Woods, S. W. (1941) DaCosta's syndrome (or effort syndrome). British Medical Journal, i, 767–769.Google Scholar
Woods, S. W., Charney, D. S., McPherson, C. A., et al (1987) Situational panic attacks. Archives of General Psychiatry, 44, 365–375.Google Scholar
Woods, S. W., Charney, D. S., Goodman, W. K., et al (1988) Carbon dioxide-induced anxiety: behavioral, physiologic, and biochemical effects of carbon dioxide in patients with panic disorders and healthy subjects. Archives of General Psychiatry, 45, 43–52.Google Scholar
Woods, S. W., Krystal, J. H., Heninger, G. R., et al (1989) Effects of alprazolam and clonidine on carbon dioxide-induced increases in anxiety ratings in healthy human subjects. Life Sciences, 45, 233–242.Google Scholar
Zohar, J., Mueller, E. A., Insel, T. R., et al (1987) Serotonergic responsiveness in obsessive compulsive disorder. Archives of General Psychiatry, 44, 946–951.Google Scholar
Zucker, D., Taylor, C. B., Brouillard, M., et al (1989) Cognitive aspects of panic attacks: content, course and relationship to laboratory stressors. British Journal of Psychiatry, 155, 86–91.Google Scholar

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.